TELADOC HEALTH, INC. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
TELADOC HEALTH, INC. (TDOC) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $10.15 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2019-04-30
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was $10.15M, a 54.50% decline year-over-year.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $22.30M, a 75.20% decline year-over-year.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was $89.93M.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $383.26M.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was -$7.39M.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was -$5.05M, a 158.53% decline from fiscal 2015.
- TELADOC HEALTH, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2015 was $8.63M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2019-03-31 | $10.15M 10-Q · filed 2019-04-30 | |||
| 2018-12-31 | $383.26M 10-K · filed 2019-02-27 | |||
| 2018-09-30 | $415.68M 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $63.69M 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | $22.30M 10-Q · filed 2019-04-30 | |||
| 2017-12-31 | -$7.39M 10-K · filed 2019-02-27 | |||
| 2017-09-30 | $33.01M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $359.21M 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $89.93M 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | -$5.05M 10-K · filed 2019-02-27 | |||
| 2016-09-30 | -$11.03M 10-Q · filed 2017-11-01 | |||
| 2015-12-31 | $8.63M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |